Results 231 to 240 of about 69,439 (335)

Initial clinical experience with dapagliflozin in addition to optimized medical therapy in paediatric heart failure patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Dapagliflozin, a sodium‐glucose cotransporter 2 (SGLT2) inhibitor, has shown clinical benefits in adults with heart failure (HF), improving cardiac function, reducing HF‐related hospitalizations and enhancing survival rates. While extensively studied in adult HF, data on its efficacy and safety in paediatric HF patients remain limited. We
Lisa‐Maria Rosenthal   +5 more
wiley   +1 more source

Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate [PDF]

open access: bronze, 2011
Henrik Reinhard   +10 more
openalex   +1 more source

Genetics, cardiac phenotype and cardiovascular outcomes in Fabry disease patients in Finland

open access: yesESC Heart Failure, EarlyView.
Abstract Aims To investigate the genetics, cardiac phenotype and cardiovascular outcomes of Finnish Fabry patients. Methods and results Among the 109 patients with Fabry disease (FD) diagnosed in Finland by 2018, 97 (89%; 32 males and 65 females, mean ages 42 and 52 years) were followed for a mean of 12 years.
Kati Valtola   +5 more
wiley   +1 more source

Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients. [PDF]

open access: yesFront Cardiovasc Med
Humayra S   +6 more
europepmc   +1 more source

NT-proBNP-Guided Preemptive Treatment of Outpatients with Chronic Heart Failure Followed in a Out Hospital Clinic [PDF]

open access: bronze, 2011
Michael Shochat   +8 more
openalex   +1 more source

Relationship of malnutrition and frailty on prolonged stay at the hospital in heart failure patients

open access: yesESC Heart Failure, EarlyView.
This abstract presents a study of 200 heart failure patients (average age 72.3 years), assessing the relationship between malnutrition and frailty. Nutritional status was evaluated using the Mini Nutritional Assessment: 63.5% had normal nutrition, 35% were at risk, and 1.5% were malnourished.
Katarzyna Lomper   +3 more
wiley   +1 more source

Association Between Malnutrition, Low Muscle Mass, Elevated NT-ProBNP Levels, and Mortality in Hemodialysis Patients. [PDF]

open access: yesNutrients
Takahashi S   +9 more
europepmc   +1 more source

A comparative study between BNP and NT-proBNP as an adjunctive diagnostic test in the acute phase of Kawasaki disease

open access: bronze, 2008
J.M. Cousineau   +7 more
openalex   +1 more source

Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients [PDF]

open access: hybrid, 2011
Silvio Romano   +8 more
openalex   +1 more source

Prognostic impact of peak oxygen consumption in heart failure: A systematic review and meta‐analysis

open access: yesESC Heart Failure, EarlyView.
Based on 64 studies, each 1 mL/kg/min increase in VO2peak significantly reduced all‐cause mortality (HR: 0.86, 95% CI 0.82–0.90) and combined outcomes of ventricular assist device, transplant and all‐cause mortality (HR: 0.84, 95% CI 0.79–0.89) in patients with heart failure, though no significant association was observed with cardiovascular mortality (
Konstantinos Prokopidis   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy